Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

Consumer Defensive Household & Personal Products Cannabis
NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

NeutriSci International Inc > NeutriSci Investor News - 07/06/2021
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(37)
•••
Comment by GAMOOD2on Jul 06, 2021 6:58pm
79 Views
Post# 33503307

RE:RE: NeutriSci Investor News - 07/06/2021

RE:RE: NeutriSci Investor News - 07/06/2021
It has come to our attention that a press release originally published on June 23, 2021 was inadvertently emailed to our shareholders today, July 6, 2021 due to a technical issue while maintenance was occurring on the NeutriSci website. Please disregard.

Thank you,

NeutriSci Investor Relations

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities